<rss version="2.0"><channel><title>BioSpace.com Featured News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Tue, 18 Jun 2013 22:07:45 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>Laboratory Corporation of America Holdings (LabCorp) Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130617006610&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0. With enhanced sensitivity...</description><pubDate>Tue, 18 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Named a ???Best Place to Work in IT??? by /i&gt; for Fifth Time  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130618005951&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles (NYSE: Q) has been named to IDGs Computerworld 100 Best Places to Work in IT list for the fifth time.&lt;br&gt;&lt;br&gt;Computerworld has recognized the top...</description><pubDate>Tue, 18 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Study  </title><link>http://www.sciencedaily.com/releases/2013/06/130615152341.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer...</description><pubDate>Mon, 17 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc. Prices Public Offering of Common Stock  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300059&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHAPEL HILL, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 14, 2013&lt;/span&gt; /PRNewswire/ --Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company...</description><pubDate>Fri, 14 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Restrictive Drug Laws Censor Science, Imperial College London and University of North Carolina Researchers Say  </title><link>http://www.timeshighereducation.co.uk/news/drugs-ban-is-scientific-censorship-says-paper/2004753.article</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The outlawing of drugs such as cannabis, magic mushrooms and other psychoactive substances amounts to scientific censorship and is hampering research into potentially important medicinal uses, leading scientists...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Medical Device Startup, Raises $13.1 Million  </title><link>http://wraltechwire.com/neurotronik-developing-medical-device-for-heart-failure-closes-13-1m-series-a/12549181/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Medical device startup NeuroTronik has raised $13.1 million for the continued development of a system to treat heart failure.The 11-month-old Chapel Hill company's first round of funding came from a syndicate...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cornerstone Therapeutics Inc. Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299967&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;CARY, NC--(Marketwired - June      13, 2013) -   Cornerstone Therapeutics Inc. (NASDAQ: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerCRTX"&gt;CRTX&lt;/a&gt;) ("Cornerstone" or the ...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Leading HIV Researchers and Argos Therapeutics, Inc. Highlight Importance of Immunotherapy in HIV Eradication Efforts  </title><link>http://www.globenewswire.com/news-release/2013/06/13/553955/10036265/en/Leading-HIV-Researchers-and-Argos-Therapeutics-Highlight-Importance-of-Immunotherapy-in-HIV-Eradication-Efforts.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., June 13, 2013 (GLOBE NEWSWIRE) -- In conjunction with the U.S. Food and Drug Administration's (FDA) June 14th Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research, leading...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc. Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300006&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHAPEL HILL, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 13, 2013&lt;/span&gt; /PRNewswire/ --Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300002&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p /&gt;&lt;p /&gt;&lt;p /&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHAPEL HILL, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 13, 2013&lt;/span&gt; /PRNewswire/ --Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;CIS&lt;/b&gt; Wins &lt;b&gt;&lt;i&gt;Triangle Business Journal's&lt;/i&gt;&lt;/b&gt; Life Sciences Award for Best Consultant  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299992&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CARY,N.C.,June 13, 2013The Triangle Business Journalannounced today thatCompliance Implementation Services(CIS), a leading life sciences consulting firm, is a winnerinitsinaugural...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; Release: Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299823&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Durham, NC  Scientists report in the current issue of STEM CELLS Translational Medicine that they are close to developing a new and effective way to treat tooth decay that fully restores the tooth rather than...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Marken (Formerly known as Marken Time Critical) Successfully Launches Quality Agreement Workshop Series  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299818&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RESEARCH TRIANGLE PARK, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 12, 2013&lt;/span&gt; /PRNewswire/ --Marken announced today the successful launch of a new workshop...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals, Inc. Announce FDA Advisory Committee to Review Relistor sNDA for Opioid-Induced Constipation in Patients With Chronic Pain  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130611005481&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RALEIGH, N.C. &amp; TARRYTOWN, N.Y.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today announced that the FDA is seeking input from an Advisory Committee...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Argos Therapeutics, Inc. Announces US and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy  </title><link>http://www.globenewswire.com/news-release/2013/06/10/553092/10035783/en/Argos-Therapeutics-Announces-US-and-Global-Expansion-for-Ongoing-Pivotal-Phase-3-ADAPT-Study-for-Personalized-Immunotherapy.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., June 10, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; Release: Novel Liver Stem Cell Model Could Speed Up Process for Developing New Drugs  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299681&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Durham, NC  The path to bringing a new drug to market is, simply put, a rocky one. Not only is it estimated to take over 12 years at an average price tag running anywhere between US $800 million and US $2 billion...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Biologics, Inc. (NC) Helps Cancer Patients Secure Over $7 Million in Copay Assistance in First Quarter  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130611005993&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CARY, N.C.--(BUSINESS WIRE)--Biologics, an integrated oncology services company, is pleased to announce that its Patient Access Services team was able to secure over $7 million in copay assistance for patients...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>BioDelivery Sciences International Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting With FDA  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299527&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RALEIGH, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 10, 2013&lt;/span&gt; /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Argos Therapeutics, Inc. Announces U.S. and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299582&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C.  June 10, 2013  Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Lab-Grown Blood Vessel Used for First Time in the U.S., Study  </title><link>http://www.sciencedaily.com/releases/2013/06/130606110026.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;A 62-year-old Virginia man with kidney failure received the first genetically engineered blood vessel in the U.S., a vein that may improve his dialysis treatments and pave the way for future tissue transplants...</description><pubDate>Fri, 07 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Birth Control Pill May Lower Ovarian Cancer Risk, Study  </title><link>http://www.reuters.com/article/2013/06/06/us-health-thepill-ovarian-cancer-idUSBRE9551AH20130606</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; Women who use birth control pills are less likely to develop ovarian cancer later in life, a new analysis of past studies suggests. Researchers pooled data from 24 studies and found Pill users had a 27 percent...</description><pubDate>Fri, 07 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Leading Publication Recognizes Legal Team Expertise  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299284&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RALEIGH, N.C.--Myers Bigel Sibley &amp; Sajovec, P.A. (Myers Bigel), the largest independent patent law firm in North Carolina with an active biotechnology practice group, is pleased to announce that eight members...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cook Medical Receives Clearance for Evolution&amp;#0174; Biliary Controlled-Release Uncovered Stent  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299138&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The Food and Drug Administration has granted 510(k) clearance for the Evolution Biliary Controlled-Release Uncovered Stent from Cook Medical. The biliary stent adds to Cooks line of Evolution controlled-release...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Genetic Editing Shows Promise in Duchenne Muscular Dystrophy, Duke University Study  </title><link>http://www.sciencedaily.com/releases/2013/06/130604153946.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Anxious? Activate Your Anterior Cingulate Cortex With a Little Meditation, Wake Forest University Baptist Medical Center Study  </title><link>http://www.wakehealth.edu/News-Releases/2013/Anxious_Activate_Your_Anterior_Cingulate_Cortex_With_a_Little_Meditation.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Scientists, like Buddhist monks and Zen masters, have known for years that meditation can reduce anxiety, but not how. Scientists at Wake Forest Baptist Medical Center, however, have succeeded in identifying...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Heart Health Matters to Your Brain, Wake Forest University Baptist Medical Center Study  </title><link>http://www.wakehealth.edu/News-Releases/2013/Heart_Health_Matters_to_Your_Brain.htm</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;People suffering from type 2 diabetes and cardiovascular disease (CVD) are at an increased risk of cognitive decline, according to a new study from Wake Forest Baptist Medical Center. Lead author Christina...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Riverside&lt;/b&gt; Partners Invests in &lt;b&gt;BioAgilytix Labs&lt;/b&gt;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299133&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;BOSTON&lt;/span&gt; and DURHAM, N.C., &lt;span class"xn-chron"&gt;June 4, 2013&lt;/span&gt; /PRNewswire/ -- Riverside Partners, a &lt;span class"xn-location"&gt;Boston&lt;/span...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Vestiq Pharmaceuticals&lt;/b&gt; Offers MagBID ER Magnesium Dietary Supplement for Patients Who Have Lost Magnesium Because of Illness or Treatment With Certain Medicines  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299176&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;MORRISVILLE, NC--(Marketwired - June      05, 2013) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href"http:/...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Blood Vessels in the Eye Linked With IQ, Cognitive Function, Duke University Study  </title><link>http://www.zmescience.com/medicine/anatomy/blood-vessels-retina-iq-04062013/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The width of blood vessels in the retina, located at the back of the eye, may indicate brain health years before the onset of dementia and other deficits, according to a new study published in Psychological...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Receives Award From Patient-Centered Outcomes Research Institute to Compare the Effectiveness of Uterine Fibroid Treatments in Real-World Practice  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130604005239&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced that it has received a research award from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of treatments...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>PerkinElmer, Inc. Recognized for Positive Contributions of its Information Technology Solutions in Health Care  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130604006112&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced the Computerworld Honors Program has named PPD a 2013 Laureate. The annual awards celebrate visionary applications...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Aerial BioPharma Release: ADX-NO5 Results Presented at Meeting  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299021&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;ADX-NO5 Results Presented at SLEEP 2013 Meeting &lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;BALTIMORE, MD- June 3, 2013 - Results from Aerial BioPharma's Phase 2a clinical trial evaluating the efficacy and safety...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Chimerix, Inc. and Biomedical Advanced Research and Development Authority (BARDA) Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox  </title><link>http://www.globenewswire.com/news-release/2013/06/03/551461/10034882/en/Chimerix-and-BARDA-Continue-Collaboration-on-Development-of-CMX001-as-a-Medical-Countermeasure-Against-Smallpox.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., June 3, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the extension of...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Renaissance&lt;/b&gt; and GlaxoSmithKline Agree to a Transfer of Nine Products  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130603006197&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MONTREAL &amp; RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Renaissance Acquisition Holdings, LLC (Renaissance), a RoundTable Healthcare Partners (RoundTable) portfolio company, and GlaxoSmithKline (LSE: GSK...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>LipoScience, Inc. Presents Data at the National Lipid Association Annual Scientific Sessions  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298633&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RALEIGH, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 31, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href"http://www.liposcience.com/" target"_blank"&gt;LipoScience, Inc&lt;...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Salix Pharmaceuticals, Ltd. Buys IP Rights Connected to Top Moneymaker  </title><link>http://www.bizjournals.com/triangle/news/2013/05/30/salix-buys-ip-rights-connected-to-top.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Salix Pharmaceuticals, Raleighs largest homegrown drug company, acquired various intellectual property rights for products that would relate to its highest revenue drug. Salix (Nasdaq: SLXP) announced Thursday...</description><pubDate>Fri, 31 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Health Diagnostic Laboratory Inc.'s New Diabetes Prevention &amp; Management Panel Incorporates Discovery From Metabolon Researchers  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298383&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RESEARCH TRIANGLE PARK, N.C.&lt;/span&gt; and &lt;span class"xn-location"&gt;RICHMOND, Va.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 29, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Bayer CropScience AG Eyes Expansion, Aims to Hire 100 Over the Next Three Years  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298365&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Bayer CropScience Breaks Ground on North American Bee Care Center &lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;Research Triangle Park, NC (PRWEB) May 29, 2013 -- As part of its continued commitment to honey bee...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>"Nano" Medicine Might Someday Free Diabetics From Daily Needles, University of North Carolina and North Carolina State University Study  </title><link>http://www.wowktv.com/story/22445451/nano-medicine-might-someday-free-diabetics-from-daily-needles</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Researchers have developed a network of so-called "nanoparticles" that theoretically could be injected into the body and release insulin to counteract rising blood sugar levels in people with diabetes. Tested...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Novan&lt;/b&gt; Announces Promising Results of SB204 Clinical Study  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298422&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;DURHAM, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 30, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href"http://www.novantherapeutics.com/" target"_blank"&gt;Novan Therapeutics...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>SCYNEXIS, Inc. Gains Worldwide Rights to Novel Antifungal Compound  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298462&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;RESEARCH TRIANGLE PARK, NC--(Marketwired - May       29, 2013) -   SCYNEXIS, Inc. announced today that Merck, known as MSD outside the United States and Canada, has decided to return...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc. Announces Notification of Patent Allowance for U.S. Patent Application on Taksta Loading Dose Formulation  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298426&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHAPEL HILL, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 30, 2013&lt;/span&gt; /PRNewswire/ -- Cempra, Inc., (Nasdaq: CEMP), a clinical-stage pharmaceutical company...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Professor Awarded Pinedo Prize  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298480&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Durham, NC  The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry &amp; Biomedical Sciences, Queens University...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Targacept, Inc. Announces Initiation of Phase 2b Study of TC-5214 in Overactive Bladder  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130529005255&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics , today announced the initiation of a Phase 2b clinical study...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Tryton Medical, Inc. Announces Successful Live Case Transmission With New Side Branch SHORT Stent  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20130529005887&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case using...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Arcato Laboratories&lt;/b&gt; Announces Execution of Term Sheet for Series A Round of Financing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298286&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;GREENSBORO, North Carolina  May 29, 2013 -- Arcato Laboratories, Inc., an emerging oral health company, announced today that it has executed a term sheet with Piedmont Angel Network (PAN), who will lead the...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>The $58 Million Antibiotic: Cempra Pharmaceuticals, Inc. Wins Five-Year Contract From Biomedical Advanced Research and Development Authority (BARDA)  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298029&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;CHAPEL HILL...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; Study: Ipilimumab Shows Durable Responses But Low Overall Response Rate in Patients With Unresectable or Metastatic Mucosal Melanoma  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298095&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, NC  Treatment with ipilimumab can result in durable antitumor effects despite a low overall response rate in patients with advanced mucosal melanoma (MM). Richard D. Carvajal, MD, Medical Oncologist...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Zenalux&lt;/b&gt; Collaborates With Leading Academic Medical Center Through Research Partnership Program, Use of Zenascope&amp;#0153; C49  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297849&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, NC  MAY 23, 2013  Zenalux Biomedical, Inc., a biomedical diagnostics company, announces Duke University as a Zenalux Research Partner. Using the Zenascope C49 in a breast tumor margin analysis study...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>LipoScience, Inc.'s Vantera&amp;#0174 Clinical Analyzer to Provide Hospitals and Physicians With Lipoprotein Analysis for Cardiovascular Disease Management  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297776&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;RALEIGH, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 22, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href"http://liposcience.com/" target"_blank"&gt;LipoScience, Inc.&lt;/a...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Salix Pharmaceuticals, Ltd. Announces Statistically Significant Results for Budesonide Foam in the Treatment of Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis in Two Pivotal Phase 3 Studies  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130522005222&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the successful completion and outcome of two pivotal Phase 3 studies to evaluate the efficacy and safety of budesonide...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Chelsea Therapeutics, Inc. to Present at the 38th Annual Deutsche Bank Health Care Conference  </title><link>http://www.globenewswire.com/news-release/2013/05/22/549007/10033677/en/Chelsea-Therapeutics-to-Present-at-the-38th-Annual-Deutsche-Bank-Health-Care-Conference.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CHARLOTTE, N.C., May 22, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference at 4:50 PM on Wednesday...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; Release: Stem Cells From Fat Outperform Those From Bone Marrow in Fighting Disease  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297513&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Durham, NC  A new study appearing in the current issue of STEM CELLS Translational Medicine indicates that stem cells harvested from fat (adipose) are more potent than those collected from bone marrow in helping...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Liquidia Technologies Inc. Announces Extension of Collaboration With PATH to Develop Next Generation Pneumococcal Vaccine  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130521005990&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced that its collaborative agreement with PATH, a global health nonprofit organization, has been extended. The extension of this...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Clinverse Announces Strategic Alliance With  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297438&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RALEIGH, NCMay 21, 2013Clinverse, Inc., a global technology and financial services company for clinical trials, announced today it has formed a strategic alliance with Aggregate Spend Solutions, LLC.  Clinverse...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130521005344&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles is the industry leader that best differentiates itself on service quality in Phase II/III clinical research, according to 157 pharmaceutical and biotechnology...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc. Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results From Patients With Community Acquired Bacterial Pneumonia (CABP)  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297297&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHAPEL HILL, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 20, 2013&lt;/span&gt; /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PurThread Technologies&lt;/b&gt; Finalist for American Technology Award in Health &amp; Medical Technologies and Advanced Manufacturing Categories  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297276&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;DURHAM, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 20, 2013&lt;/span&gt; /PRNewswire/ -- The antimicrobial textile technology being developed by &lt;a href"http:...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Argos Therapeutics, Inc. to Present at the  </title><link>http://www.globenewswire.com/news-release/2013/05/20/548369/10033339/en/Argos-Therapeutics-to-Present-at-the-Sachs-Cancer-Bio-Partnering-Forum.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., May 20, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Aerocrine Announces Presentation of Data on FeNO Testing in Overlap Syndrome at American Thoracic Society 2013  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130520005710&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Aerocrine AB (OMX Nordic Exchange: AERO) ---Aerocrine, Inc. today announced the following scientific abstract, Characterization of Allergic Airway Inflammation in Patients with COPD using Fractional exhaled...</description><pubDate>Mon, 20 May 2013 12:00:00 AM GMT</pubDate></item><item><title>"Cyber" Attacks on Your Heart? University of Michigan and University of South Carolina Scientists Test the E-Security of Pacemakers  </title><link>http://www.sciencedaily.com/releases/2013/05/130516123920.htm</link><description> Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The type of sensors that pick up the rhythm of a beating heart in implanted cardiac defibrillators and pacemakers are vulnerable to tampering, according to a new study conducted in controlled laboratory conditions...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130516005868&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the Panel) has granted the Companys request for continued listing...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>BioDuro, LLC Opens State-of-the-Art Discovery Lab in Shanghai  </title><link>http://www.chinabiotoday.com/articles/20130516_1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WILMINGTON, N.C.--(BUSINESS WIRE)--BioDuro, A PPD Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Salix Pharmaceuticals, Ltd. Outlines Data Presentations at 
  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130517005016&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that presentations related to the investigation of two of the Companys products are scheduled to take place during Digestive Disease Week DDW2013...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc. Cutting 400 Jobs Worldwide This Year  </title><link>http://www.newsobserver.com/2013/05/14/2892710/quintiles-cutting-400-jobs-worldwide.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; On the heels of last weeks successful initial public offering that raised hundreds of million of dollars from investors, pharmaceutical services giant Quintiles disclosed Tuesday in a securities filing that...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Tryton Medical, Inc. Announces CE Mark and European Launch of Next-Generation Tryton Side Branch SHORT Stent  </title><link>http://www.businesswire.com/portal/site/biospace2/index.jsp?ndmViewId=news_view&amp;newsId=20130516005870&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, today announced that the company received the CE Mark for the Tryton Side Branch SHORT...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; Release: New Stem Cell Growth Strategy Could Yield Better Way to Treat Brain Lesions  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296991&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Durham, NC  Researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;DebMed&lt;/b&gt; Announces US Patent  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296990&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt; &lt;div class"xn-content"&gt;&lt;p&gt;&lt;span class"xn-location"&gt;CHARLOTTE, N.C.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 16, 2013&lt;/span&gt; /PRNewswire/ -- &lt;a href"http://www.debmed.com/" target"_blank"&gt;DebMed&lt;/a&gt;, creator...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Oxygen Biotherapeutics, Inc. Receives Favorable Listing Decision  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130516005868&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the Panel) has granted the Companys request for continued listing...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>INC Research, Inc. Announces 2013 "Perspectives" Webinar Series  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297039&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Raleigh, N.C., May 15, 2013  INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process for delivering reliable results, today announced it will kick off...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>PPD, Inc. Earns Award for Innovation in Training and Development  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130516005725&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced that Skillsoft has named PPD a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Chimerix, Inc.'s CMX001 Resistance Data Presented at the  </title><link>http://www.globenewswire.com/news-release/2013/05/16/547751/10033060/en/Chimerix-s-CMX001-Resistance-Data-Presented-at-the-26th-International-Conference-on-Antiviral-Research.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., May 16, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, recently presented data demonstrating...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;AlphaMed&lt;/b&gt; - New Study Shows: Reduced Oxygen Levels Could Double Neural Stem Cells??? Chance of Survival  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296824&amp;full=1</link><description>Durham, NC  Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according to a new study released today in STEM CELLS Translational Medicine.&lt;/p&gt;&lt;p&gt;Cells are usually cultured in the lab in a 20 percent oxygen environment, a level far removed from the in vivo situation...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Merck Serono and Quintiles, Inc. Announce Innovative Clinical Development Partnership  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130515005861&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, the worlds largest provider of biopharmaceutical development and commercial outsourcing services...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Helping to Publicize Event Via NCTechNews, News Sites  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296806&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--Innovative PR and media relations firm Global Media Strategies (www.gmsinnovate.com) is supporting the world's largest multi-disciplinary multi-sector conference and marketplace...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc., Toyama Chemical Company Ink Up to $70 Million Pact to Produce Anti-Pneumonia Drug  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296466&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;b&gt;Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin With Toyama Chemical Co., Ltd., a Subsidiary of FUJIFILM Holdings Corporation in Japan&lt;/b&gt;&lt;br&gt;&lt;br&gt;Read more here: http...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>LipoScience, Inc. to Present at UBS Global Healthcare Services Conference  </title><link>http://www.globenewswire.com/news-release/2013/05/14/546909/10032646/en/LipoScience-to-Present-at-UBS-Global-Healthcare-Services-Conference.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RALEIGH, N.C., May 14, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that Richard Brajer, President and Chief Executive Officer, and Lucy Martindale, Executive Vice President and Chief...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Chimerix, Inc. Announces First Quarter 2013 Financial Results  </title><link>http://www.globenewswire.com/news-release/2013/05/13/546459/10032497/en/Chimerix-Announces-First-Quarter-2013-Financial-Results.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;DURHAM, N.C., May 13, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today reported financial results...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Chiltern International Ltd. Announces Senior Appointments Aimed at Securing the Company's Continued Success and Future Growth  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296462&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;London, UK, and Wilmington, NC, US, May 13, 2013: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announces the appointments of Dr Manuela Niewel and Lisa Bull to secure...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Quintiles, Inc.'s $947.4M IPO  to Spawn a New Billionaire  </title><link>http://www.forbes.com/sites/matthewherper/2013/05/08/the-next-billionaire-a-statistician-who-changed-medicine/</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles today announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item></channel></rss>